Camp4 Therapeutics (CAMP) Non-cash Items (2023 - 2024)
Camp4 Therapeutics' (CAMP) quarterly Non-cash Items came in at $1.0 million in Q3 2024, down 85.46% quarter-over-quarter from $6.9 million in Q4 2023.
Camp4 Therapeutics (CAMP) Non-cash Items (2023 - 2024) Analysis & Trends
Camp4 Therapeutics has disclosed Non-cash Items across 2 years of filings, most recently posting $1.0 million for Q3 2024.
- Non-cash Items for Q3 2024 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $1.0 million (changed N/A YoY), and the FY2023 annual result was $6.9 million, changed N/A from the prior year.
- Non-cash Items came in at $1.0 million for Q3 2024 at Camp4 Therapeutics, down from $6.9 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $6.9 million in Q4 2023 to a low of $1.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Dec 31, 2023 | 6.89 Mn |
| Dec 31, 2023 | 6.89 Mn |